| Symbol: |
LILRA1
|
| Description: |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 [Source:HGNC Symbol;Acc:6602]
|
| Location: |
Chr19:55105047-55113555[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:191
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| LILRA1 |
NSC 682007 |
0.044 |
Down |
| LILRA1 |
NSC 682131 |
0.024 |
Down |
| LILRA1 |
5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- |
0.001 |
Up |
| LILRA1 |
Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- |
0.034 |
Down |
| LILRA1 |
NSC 683555 |
0.016 |
Down |
| LILRA1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4-ethyl- 11-[[[4-[[5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy- 3,5-dimethoxyphenyl)-6-oxofuro[3',4':6,7]naphtho[2,3-d]- 1,3-dioxol-9-yl]amino]phenyl]imino]methyl]-4-hydroxy-, hydrochloride, ste |
0.031 |
Down |
| LILRA1 |
NSC 684807 |
0.022 |
Down |
| LILRA1 |
NSC 685265 |
0.001 |
Down |
| LILRA1 |
3-Pyridinecarboxylic acid, 4-[2-cyano-2-(ethoxycarbonyl)-1- (2-phenyhydrazino)ethenyl]- |
0.03 |
Down |
| LILRA1 |
Dipyrazolo[3,4-f:3',4'-g]-2-pyrindine-3,4(2H,5H)-dione, 2,5-diphenyl- |
0.027 |
Down |
| LILRA1 |
NSC 685964 |
0.013 |
Down |
| LILRA1 |
NSC 686474 |
0.013 |
Up |
| LILRA1 |
NSC 687748 |
0.031 |
Down |
| LILRA1 |
Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (1,4-dioxo-2-naphthalenyl)methyl ester |
0.034 |
Down |
| LILRA1 |
NSC 688715 |
0.04 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:6
First Prev Next Last 
|
| SNP:
~ Export ~
|
Records:114
Total:8 Current:1
[First] [Prev]  Next Last 
|
| miRNA:
~ Export ~
|
Records:54
Total:4 Current:1
[First] [Prev]  Next Last 
|